• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic

    Thumbnail
    View/Open
    Cochrane426423-Accepted.pdf (307.3Kb)
    File version
    Accepted Manuscript (AM)
    Author(s)
    Di Ciaccio, Pietro
    McCaughan, Georgia
    Trotman, Judith
    Ho, Phoebe Joy
    Cheah, Chan Y
    Gangatharan, Shane
    Wight, Joel
    Ku, Matthew
    Quach, Hang
    Gasiorowski, Robin
    Polizzotto, Mark N
    Prince, Henry Miles
    Mulligan, Stephen
    Tam, Constantine S
    Gregory, Gareth
    Hapgood, Greg
    Spencer, Andrew
    Dickinson, Michael
    Latimer, Maya
    Johnston, Anna
    Armytage, Tasman
    Lee, Cindy
    Cochrane, Tara
    Berkhahn, Leanne
    Weinkove, Robert
    Doocey, Richard
    Harrison, Simon J
    Webber, Nicholas
    Lee, Hui-Peng
    Chapman, Scott
    Campbell, Belinda A
    Gibbs, Simon DJ
    Hamad, Nada
    Griffith University Author(s)
    Cochrane, Tara
    Year published
    2020
    Metadata
    Show full item record
    Abstract
    The COVID-19 pandemic poses a unique challenge to the care of patients with haematological malignancies. Viral pneumonia is known to cause disproportionately severe disease in patients with cancer, and patients with lymphoma, myeloma and chronic lymphocytic leukaemia are likely to be at particular risk of severe disease related to COVID-19. This statement has been developed by consensus among authors from Australia and New Zealand. We aim to provide supportive guidance to clinicians making individual patient decisions during the COVID-19 pandemic, in particular during periods that access to healthcare resources may be limited. ...
    View more >
    The COVID-19 pandemic poses a unique challenge to the care of patients with haematological malignancies. Viral pneumonia is known to cause disproportionately severe disease in patients with cancer, and patients with lymphoma, myeloma and chronic lymphocytic leukaemia are likely to be at particular risk of severe disease related to COVID-19. This statement has been developed by consensus among authors from Australia and New Zealand. We aim to provide supportive guidance to clinicians making individual patient decisions during the COVID-19 pandemic, in particular during periods that access to healthcare resources may be limited. General recommendations include those to minimise patient exposure to COVID-19, including the use of telehealth, avoidance of non-essential visits and minimisation of time spent by patients in infusion suites and other clinical areas. This statement also provides recommendations where appropriate in assessing indications for therapy, reducing therapy-associated immunosuppression and reducing healthcare utilisation in patients with specific haematological malignancies during the COVID-19 pandemic. Specific decisions regarding therapy of haematological malignancies will need to be individualised, based on disease risk, risks of immunosuppression, rates of community transmission of COVID-19 and available local healthcare resources.
    View less >
    Journal Title
    Internal Medicine Journal
    DOI
    https://doi.org/10.1111/imj.14859
    Copyright Statement
    © 2020 Royal Australasian College of Physicians. This is the peer reviewed version of the following article: Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic, Internal Medicine Journal, 2020, which has been published in final form at https://doi.org/10.1111/imj.14859. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html)
    Note
    This publication was entered as an advanced online version.
    Subject
    Cardiovascular medicine and haematology
    Clinical sciences
    Health services and systems
    Public health
    COVID-19
    chronic lymphocytic leukaemia
    lymphoma
    myeloma
    Publication URI
    http://hdl.handle.net/10072/394053
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander